Navigation Links
Scripps research scientists model 3D structures of proteins that control human clock
Date:4/10/2009

model organism to study genes.

Like all plants, this plant contains proteins known as photolyases, which use blue light to repair DNA damage induced by ultraviolet light. Photolyases have also been found in bacteria and in some animals, but not in human cells. Humans and mammals, on the other hand, possess a homologous protein known as cryptochrome that modulates the circadian clock.

"This is an amazing, and very puzzling, family of proteins, because they do one thing in plants and quite a different thing in mammals, yet these cousins all have the same structure and need the same cofactor, or chemical compound, to become activated," Getzoff says.

"All of these proteins were probably originally responses to sunlight," Hitomi adds. "Sunlight causes DNA damage, so plants need to repair this damage, and they also need to respond to sunlight and seasons for growth and flowering. The human clock is set by exposure to sunlight, but also by when we eat, sleep, and exercise."

In this study, Hitomi set about producing proteins from the Arabidopsis thaliana genes that produce two related photolyase enzymes. These genes had been cloned earlier in the laboratory of co-author Takeshi Todo, Ph.D., of Kyoto University, with whom Hitomi previously studied.

He moved the gene from the plant into E. coli bacteria to produce a lot of the protein, which he then crystallized to determine the atomic structure by using X-ray diffraction. The researchers then produced a variety of mutant proteins in order to test the functional structure of the enzymes.

"We can now look at things that are the same and different between human and mouse cryptochromes and plant photolyases," says Hitomi. "Our results provide a detailed, comparative framework for biological investigations of both of these proteins and their functions."

Not only do the findings have the potential to form the basis of drugs that can ease jet lag and regulate drug metabol
'/>"/>

Contact: Keith McKeown
kmckeown@scripps.edu
858-784-8134
Scripps Research Institute
Source:Eurekalert

1

GOOD

Page: 1 2 3

Related medicine news :

1. Scripps Health Selects Allscripts for Electronic Health Record
2. Scripps research scientists engineer new type of vaccination that provides instant immunity
3. Scripps research scientists develop general-purpose method for detecting trace chemicals
4. Team led by Scripps Scientists increases understanding of two types of blindness
5. KRAUSE, KALFAYAN, BENINK & SLAVENS, LLP, Announces Filing a Class Action Lawsuit Against Scripps Health, et al.
6. Scripps Health Enhances Employee Wellness Program With Home Testing Solutions From BioIQ
7. Scripps Research Institute and IAVI launch worlds first dedicated HIV neutralizing antibody center
8. Scripps Translational Science Institute Contributes to Discovery of Predisposition Gene for Childhood Cancer
9. Scripps research team unravels new cellular repair mechanism
10. Scripps Research scientists find seizure drug reverses cellular effects
11. Scripps Memorial Hospital Nurses Throw Out CNA
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/16/2009)... myopia now than in the ,70s, study finds , , ... more common in the United States than it was ... study shows. , Researchers compared National Health and Nutrition ... from 1971 to 1972 and from 8,339 black and ... 12 to 54 years old. , The prevalence of ...
(Date:12/16/2009)... earn a free 21-count one week trial bottle sample with purchase ... ... December 16, 2009 -- ImmuneResponse247.com announces a special ... Immune Response 247™ 6 Mushroom Formula , with the purchase ... 247™ 6 Mushroom Formula is packaged in FDA approved facilities and ...
(Date:12/16/2009)... proud to announce being presented with the Weatherhead 100 Upstart Award ... growing companies in Northeast Ohio and is a testament to hard ... , ... (PRWEB) December 16, 2009 -- Request A ... 100 Upstart Award on December 3, 2009. The Weatherhead 100 ...
(Date:12/16/2009)... the perfect gift to give that special woman who has everything? ... Esthetician Mary Schook introduces exceptional beauty products online while educating the ... ... (PRWEB) December 16, 2009 -- The holidays are rapidly ... special woman who has everything? Why stem cells, of course!, , ...
(Date:12/15/2009)... SUMMARY: The U.S. Senate today rejected ... Care Act that would have helped make prescription ... and legal importation of lower priced drugs from ... sponsored by Senators Dorgan, Snowe, McCain, Grassley and ... bring down the skyrocketing costs of prescription drugs. ...
Breaking Medicine News(10 mins):Health News:Free Sample of Proven Health Mushroom Supplement Offered By ImmuneResponse247.com 2Health News:Free Sample of Proven Health Mushroom Supplement Offered By ImmuneResponse247.com 3Health News:Free Sample of Proven Health Mushroom Supplement Offered By ImmuneResponse247.com 4Health News:Request A Test Receives Weatherhead 100 Upstart Award 2Health News:New Online Beauty Store Suggests Stem Cells for the Woman Who Has Everything 2Health News:AARP Disappointed By Senate Vote Against Lower Prescription Drug Prices 2Health News:AARP Disappointed By Senate Vote Against Lower Prescription Drug Prices 3
... to the issue of self harm. Self-Harm is most often ... support, help and above all, understanding. According to a recent ... to help a person who self-harms. ,The "see ... to the fore - that nearly 41% of adults ...
... has now established that a delayed-release stimulant, used for ... with less abuse, when compared to other stimulant drugs//. ... an oral formulation have not been reported to produce ... results of the study can be found in the ...
... is a major cause of depression and Alzheimer's disease in ... which shrinks in old age resulting in depression and Alzheimer's ... develop new treatments for Alzheimer’s disease. ,The shrinkage ... cortex result in the release of high levels of stress ...
... Paris: The French government is bracing itself to tackle a ... called the Chikungunya Fever, known to be spread by mosquitoes// ... poses a risk of entering into France. ,According ... infected one fifth of La Reunion's population , and many ...
... P's and Q's, trim your hair, cut your nails, polish your ... women, no gaudy saris please //-- just some of the do's ... visit. ,Tips on how to look and what to ... prime minister and visiting dignitaries along with the special protection group ...
... has commended India for the alacrity with which the ... in the country in the last fortnight. // ... They have told us the quick response of the ... Husbandry) Upma Chowdhury informed reporters. "India's actions have added ...
Other Medicine News:Health News:Concerta, Drug Used in ADHD Treatment Less Likely To Result In Abuse 2Health News:Mind your looks for Bush visit, as world is watching 2
(Date:12/16/2009)... Naurex Inc., a new clinical stage company developing ... based on its novel GFPA NMDA receptor modulators, ... I clinical trial of its lead compound GLYX-13 ... the study. GLYX-13, a glycine site functional ... receptor, is initially being developed as a therapy ...
(Date:12/16/2009)... Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX ) ... 3 registration clinical trial for KRX-0401 (perifosine), ... / refractory multiple myeloma patients. ,, The ... to Assess the Efficacy and Safety of ... (Velcade®) and Dexamethasone in Multiple Myeloma Patients ...
(Date:12/15/2009)... Ireland, Dec. 15 Warner Chilcott plc ... subsidiary Warner Chilcott Corporation (the "Company") has commenced ... subject to the conditions set forth in the ... dated December 15, 2009 (the "Offer to Purchase"), ... senior subordinated notes due 2015 (the "Notes"). ,, ...
Breaking Medicine Technology:Naurex Inc. Initiates Phase I Clinical Trial of its Novel Mechanism NMDA Modulator GLYX-13 in Treatment-Resistant Depression 2Naurex Inc. Initiates Phase I Clinical Trial of its Novel Mechanism NMDA Modulator GLYX-13 in Treatment-Resistant Depression 3Keryx Biopharmaceuticals, Inc. Initiates Phase 3 Registration Trial of KRX-0401 (Perifosine) for Treatment of Patients with Advanced Multiple Myeloma 2Keryx Biopharmaceuticals, Inc. Initiates Phase 3 Registration Trial of KRX-0401 (Perifosine) for Treatment of Patients with Advanced Multiple Myeloma 3Keryx Biopharmaceuticals, Inc. Initiates Phase 3 Registration Trial of KRX-0401 (Perifosine) for Treatment of Patients with Advanced Multiple Myeloma 4Keryx Biopharmaceuticals, Inc. Initiates Phase 3 Registration Trial of KRX-0401 (Perifosine) for Treatment of Patients with Advanced Multiple Myeloma 5Keryx Biopharmaceuticals, Inc. Initiates Phase 3 Registration Trial of KRX-0401 (Perifosine) for Treatment of Patients with Advanced Multiple Myeloma 6Keryx Biopharmaceuticals, Inc. Initiates Phase 3 Registration Trial of KRX-0401 (Perifosine) for Treatment of Patients with Advanced Multiple Myeloma 7Warner Chilcott Commences Tender Offer for its 8.75% Senior Subordinated Notes due 2015 2Warner Chilcott Commences Tender Offer for its 8.75% Senior Subordinated Notes due 2015 3Warner Chilcott Commences Tender Offer for its 8.75% Senior Subordinated Notes due 2015 4Warner Chilcott Commences Tender Offer for its 8.75% Senior Subordinated Notes due 2015 5Warner Chilcott Commences Tender Offer for its 8.75% Senior Subordinated Notes due 2015 6Scientists closer to making implantable bone material thanks to new research 9358 1Scientists closer to making implantable bone material thanks to new research 9358 2Assara Laser Hair Removal Centers 28New York NY 29 Receives 2008 New York Award for Cosmetology 26amp 3B Personal Hygiene Salons by the U S C A 52713 1Assara Laser Hair Removal Centers 28New York NY 29 Receives 2008 New York Award for Cosmetology 26amp 3B Personal Hygiene Salons by the U S C A 52713 2SpeechEasy Seeks Proposals For Future Research Studies 52708 1SpeechEasy Seeks Proposals For Future Research Studies 52708 2SpeechEasy Seeks Proposals For Future Research Studies 52708 3
... CAMBRIDGE, Mass.--(BUSINESS WIRE)--Jun 25, 2007 - Elixir,Pharmaceuticals, ... sets,of preclinical data demonstrating that ghrelin antagonism ... of a range of metabolic,disorders. These data ... decreasing body weight, improvements in,blood glucose and ...
... highly potent DPP-4 inhibitor, possessing Ki of 27,pM, ... a privately held drug discovery biopharmaceutical company,announced today ... presented at the 67th session of the American ... that,ARI-2243 is an extremely long acting, potent inhibitor ...
Other Medicine Technology:Elixir Pharmaceuticals Presents Preclinical Data Highlighting Its,Ghrelin Antagonist Program at the American Diabetes Association's,Annual Meeting 2Elixir Pharmaceuticals Presents Preclinical Data Highlighting Its,Ghrelin Antagonist Program at the American Diabetes Association's,Annual Meeting 3Elixir Pharmaceuticals Presents Preclinical Data Highlighting Its,Ghrelin Antagonist Program at the American Diabetes Association's,Annual Meeting 4Arisaph Pharmaceuticals Announces Results of its Potent Smart DPP-4,Inhibitor, ARI-2243, at the ADA 2Arisaph Pharmaceuticals Announces Results of its Potent Smart DPP-4,Inhibitor, ARI-2243, at the ADA 3Arisaph Pharmaceuticals Announces Results of its Potent Smart DPP-4,Inhibitor, ARI-2243, at the ADA 4
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: